Addition of host genetic variants in a prediction rule for post meningitis hearing loss in childhood: a model updating study

BMC Infectious Diseases

A Marceline van Furth³  Servaas A Morré²  Lodewijk Spanjaard⁴  Sander Ouburg⁶  Irene Koomen¹  Martijn W Heymans⁵  Caroline B Terwee⁵  Rogier CJ de Jonge⁷  Marieke S Sanders⁶ 

[1] Department of Pediatrics, Westfriesgasthuis, Hoorn, The Netherlands;Department of Genetics and Cell Biology, Institute for Public Health Genomics, Research Schools GROW and CAPHRI, Faculty of Health, Medicine & Life Sciences, University of Maastricht, Maastricht, The Netherlands;Department of Pediatric Infectious Diseases - Immunology, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands;Department of Medical Microbiology, Netherlands Reference Laboratory for Bacterial Meningitis, Academic Medical Center, Amsterdam, The Netherlands;Department of Epidemiology and Biostatistics and the EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands;Department of Medical Microbiology, Laboratory for Immunogenetics, VU University Medical Center, Amsterdam, The Netherlands;Department of Neonatology, Erasmus MC - Sophia Children’s Hospital, Room Sp-3434, PO-box 2040, Rotterdam, 3000 CB The Netherlands

关键词: Child;    Hearing loss;    Bacterial meningitis;    Prediction;    Risk;    SNP;    Genetics;   

Others  :  1146788
DOI  :  10.1186/1471-2334-13-340

 received in 2012-12-23, accepted in 2013-07-16,  发布年份 2013

【 摘 要 】

Background

Sensorineural hearing loss is the most common sequela in survivors of bacterial meningitis (BM). In the past we developed a validated prediction model to identify children at risk for post-meningitis hearing loss. It is known that host genetic variations, besides clinical factors, contribute to severity and outcome of BM. In this study it was determined whether host genetic risk factors improve the predictive abilities of an existing model regarding hearing loss after childhood BM.

Methods

Four hundred and seventy-one Dutch Caucasian childhood BM were genotyped for 11 single nucleotide polymorphisms (SNPs) in seven different genes involved in pathogen recognition. Genetic data were added to the original clinical prediction model and performance of new models was compared to the original model by likelihood ratio tests and the area under the curve (AUC) of the receiver operating characteristic curves.

Results

Addition of TLR9-1237 SNPs and the combination of TLR2 + 2477 and TLR4 + 896 SNPs improved the clinical prediction model, but not significantly (increase of AUC’s from 0.856 to 0.861 and from 0.856 to 0.875 (p = 0.570 and 0.335, respectively). Other SNPs analysed were not linked to hearing loss.

Conclusions

Although addition of genetic risk factors did not significantly improve the clinical prediction model for post-meningitis hearing loss, AUC’s of the pre-existing model remain high after addition of genetic factors. Future studies should evaluate whether more combinations of SNPs in larger cohorts has an additional value to the existing prediction model for post meningitis hearing loss.

【 授权许可】

   
2013 Sanders et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Roizen NJ: Etiology of hearing loss in children. Nongenetic causes. Pediatr Clin North Am 1999, 46(1):49-64. x
• [2]Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I: Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis 2010, 10(5):317-328.
• [3]Koomen I, Grobbee DE, Roord JJ, Donders R, Jennekens-Schinkel A, van Furth AM: Hearing loss at school age in survivors of bacterial meningitis: assessment, incidence, and prediction. Pediatrics 2003, 112(5):1049-1053.
• [4]Kutz JW, Simon LM, Chennupati SK, Giannoni CM, Manolidis S: Clinical predictors for hearing loss in children with bacterial meningitis. Arch Otolaryngol Head Neck Surg 2006, 132(9):941-945.
• [5]Worsoe L, Caye-Thomasen P, Brandt CT, Thomsen J, Ostergaard C: Factors associated with the occurrence of hearing loss after pneumococcal meningitis. Clin Infect Dis 2010, 51(8):917-924.
• [6]Merkus P, Free RH, Mylanus EA, Stokroos R, Metselaar M, van Spronsen E, Grolman W, Frijns JH, 4th Consensus in Auditory Implants Meeting: Dutch Cochlear Implant Group (CI-ON) consensus protocol on postmeningitis hearing evaluation and treatment. Otol Neurotol 2010, 31(8):1281-1286.
• [7]de Jonge RCJ, Sanders MS, Terwee CB, Heymans MW, Gemke RJBJ, Koomen I, Spanjaard L, van Furth AM: Independent validation of an existing model enables prediction of hearing loss after Childhood bacterial meningitis. PLoS One 2013, 8(3):e58707.
• [8]Emonts M, Hazelzet JA, de Groot R, Hermans PW: Host genetic determinants of Neisseria meningitidis infections. Lancet Infect Dis 2003, 3(9):565-577.
• [9]Sanders MS, van Well GT, Ouburg S, Morre SA, van Furth AM: Genetic variation of innate immune response genes in invasive pneumococcal and meningococcal disease applied to the pathogenesis of meningitis. Genes Immun 2011, 12(5):321-334.
• [10]Faber J, Henninger N, Finn A, Zenz W, Zepp F, Knuf M: A toll-like receptor 4 variant is associated with fatal outcome in children with invasive meningococcal disease. Acta Paediatr 2009, 98(3):548-552.
• [11]Yuan FF, Marks K, Wong M, Watson S, de Leon E, McIntyre PB, Sullivan JS: Clinical relevance of TLR2, TLR4, CD14 and FcgammaRIIA gene polymorphisms in Streptococcus pneumoniae infection. Immunol Cell Biol 2008, 86(3):268-270.
• [12]Klein M, Obermaier B, Angele B, Pfister HW, Wagner H, Koedel U, Kirschning CJ: Innate immunity to pneumococcal infection of the central nervous system depends on toll-like receptor (TLR) 2 and TLR4. J Infect Dis 2008, 198(7):1028-1036.
• [13]Koedel U, Rupprecht T, Angele B, Heesemann J, Wagner H, Pfister HW, Kirschning CJ: MyD88 is required for mounting a robust host immune response to Streptococcus pneumoniae in the CNS. Brain : a journal of neurology 2004, 127(Pt 6):1437-1445.
• [14]Klein M, Schmidt C, Kastenbauer S, Paul R, Kirschning CJ, Wagner H, Popp B, Pfister HW, Koedel U: MyD88-dependent immune response contributes to hearing loss in experimental pneumococcal meningitis. J Infect Dis 2007, 195(8):1189-1193.
• [15]Klein M, Koedel U, Kastenbauer S, Pfister HW: Nitrogen and oxygen molecules in meningitis-associated labyrinthitis and hearing impairment. Infection 2008, 36(1):2-14.
• [16]van Well GT, Sanders MS, Ouburg S, van Furth AM, Morre SA: Polymorphisms in Toll-like receptors 2, 4, and 9 are highly associated with hearing loss in survivors of bacterial meningitis. PLoS One 2012, 7(5):e35837.
• [17]Netherlands Reference Laboratory for Bacterial Meningitis: Bacterial meningitis in the Netherlands: annual report 2009. Amsterdam: The Netherlands: AMC/RIVM; 2010.
• [18]Landgraf JM, Abetz L, Ware JE: The CHQ user’s manual. Boston. The Health Institute, New England Medical Center. Boston: The Health Institute, New England Medical Center; 1996.
• [19]Raat H, Bonsel GJ, Essink-Bot ML, Landgraf JM, Gemke RJ: Reliability and validity of comprehensive health status measures in children: The Child Health Questionnaire in relation to the Health Utilities Index. J Clin Epidemiol 2002, 55(1):67-76.
• [20]Theiner G, Rossner S, Dalpke A, Bode K, Berger T, Gessner A, Lutz MB: TLR9 cooperates with TLR4 to increase IL-12 release by murine dendritic cells. Mol Immunol 2008, 45(1):244-252.
• [21]Lazarus R, Vercelli D, Palmer LJ, Klimecki WJ, Silverman EK, Richter B, Riva A, Ramoni M, Martinez FD, Weiss ST, et al.: Single nucleotide polymorphisms in innate immunity genes: abundant variation and potential role in complex human disease. Immunol Rev 2002, 190:9-25.
• [22]Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW: Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 2010, 21(1):128-138.
• [23]Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR: A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996, 49(12):1373-1379.
• [24]Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS: Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008, 27(2):157-172. discussion 207–112
• [25]R Development Core Team: R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2008. URL http://www.R-project.org webcite
• [26]Pencina MJ, D’Agostino RB Sr, Steyerberg EW: Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011, 30(1):11-21.
• [27]Sanders MS, van Well GT, Ouburg S, Lundberg PS, van Furth AM, Morre SA: Single nucleotide polymorphisms in TLR9 are highly associated with susceptibility to bacterial meningitis in children. Clin Infect Dis 2011, 52(4):475-480.
• [28]Sanders MS, van Well GT, Ouburg S, Morre SA, van Furth AM: Toll-like receptor 9 polymorphisms are associated with severity variables in a cohort of meningococcal meningitis survivors. BMC Infect Dis 2012, 12:112. BioMed Central Full Text
• [29]Harris JP, Ryan AF: Fundamental immune mechanisms of the brain and inner ear. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 1995, 112(6):639-653.
• [30]Toll DB, Janssen KJ, Vergouwe Y, Moons KG: Validation, updating and impact of clinical prediction rules: a review. J Clin Epidemiol 2008, 61(11):1085-1094.
• [31]Willems SM, Mihaescu R, Sijbrands EJ, van Duijn CM, Janssens AC: A methodological perspective on genetic risk prediction studies in type 2 diabetes: recommendations for future research. Curr Diab Rep 2011, 11(6):511-518.
• [32]van der Helm-van Mil AH, Toes RE, Huizinga TW: Genetic variants in the prediction of rheumatoid arthritis. Ann Rheum Dis 2010, 69(9):1694-1696.
• [33]Takahashi H, Nakajima M, Ozaki K, Tanaka T, Kamatani N, Ikegawa S: Prediction model for knee osteoarthritis based on genetic and clinical information. Arthritis Res Ther 2010, 12(5):R187. BioMed Central Full Text
• [34]Janssens AC, Ioannidis JP, van Duijn CM, Little J, Khoury MJ, Group G: Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. BMJ 2011, 342:d631.
• [35]Jayarajan V, Patton MA, Rajenderkumar D: Genetic predisposition and sensorineural hearing loss following bacterial meningitis: is there a link? J Infect 2002, 44(3):210.
• [36]Goldstein DB: Common genetic variation and human traits. N Engl J Med 2009, 360(17):1696-1698.
• [37]Brand A, Brand H, Schulte in den Baumen T: The impact of genetics and genomics on public health. Europ J hum gen : EJHG 2008, 16(1):5-13.
• [38]Brand A: Public health genomics--public health goes personalized? Eur J Public Health 2011, 21(1):2-3.
• [39]Lal JA, Schulte In den Baumen T, Morre SA, Brand A: Public health and valorization of genome-based technologies: a new model. J Transl Med 2011, 9:207. BioMed Central Full Text
• [40]Kopelovich JC, Germiller JA, Laury AM, Shah SS, Pollock AN: Early prediction of postmeningitic hearing loss in children using magnetic resonance imaging. Arch Otolaryngol Head Neck Surg 2011, 137(5):441-447.
• [41]Brookhouser PE: Fluctuating sensorineural hearing loss in children. Otolaryngol Clin North Am 2002, 35(4):909-923. ix